France · Delayed Price · Currency is EUR Neurones Statistics
Total Valuation
Neurones has a market cap or net worth of EUR 867.56 million. The enterprise value is 638.58 million.
| Market Cap | 867.56M |
| Enterprise Value | 638.58M |
Important Dates
The next estimated earnings date is Wednesday, September 16, 2026.
| Earnings Date | Sep 16, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Neurones has 23.87 million shares outstanding.
| Current Share Class | 23.87M |
| Shares Outstanding | 23.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.50% |
| Owned by Institutions (%) | 7.95% |
| Float | 11.62M |
Valuation Ratios
The trailing PE ratio is 15.70 and the forward PE ratio is 15.61.
| PE Ratio | 15.70 |
| Forward PE | 15.61 |
| PS Ratio | 0.98 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.17 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.75, with an EV/FCF ratio of 8.96.
| EV / Earnings | 11.55 |
| EV / Sales | 0.72 |
| EV / EBITDA | 6.75 |
| EV / EBIT | 7.77 |
| EV / FCF | 8.96 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 46.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 32.95% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.58% |
| Revenue Per Employee | 125,042 |
| Profits Per Employee | 7,786 |
| Employee Count | 7,208 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Neurones has paid 25.32 million in taxes.
| Income Tax | 25.32M |
| Effective Tax Rate | 27.64% |
Stock Price Statistics
The stock price has decreased by -11.23% in the last 52 weeks. The beta is 0.42, so Neurones's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -11.23% |
| 50-Day Moving Average | 36.88 |
| 200-Day Moving Average | 37.76 |
| Relative Strength Index (RSI) | 46.59 |
| Average Volume (20 Days) | 5,169 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neurones had revenue of EUR 887.68 million and earned 55.27 million in profits.
| Revenue | 887.68M |
| Gross Profit | 448.87M |
| Operating Income | 82.18M |
| Pretax Income | 91.57M |
| Net Income | 55.27M |
| EBITDA | 94.60M |
| EBIT | 82.18M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 12.42M |
| Net Borrowing | n/a |
| Free Cash Flow | 71.28M |
| FCF Per Share | 2.99 |
Margins
Gross margin is 50.57%, with operating and profit margins of 9.26% and 6.23%.
| Gross Margin | 50.57% |
| Operating Margin | 9.26% |
| Pretax Margin | 10.32% |
| Profit Margin | 6.23% |
| EBITDA Margin | 10.66% |
| EBIT Margin | 9.26% |
| FCF Margin | 8.17% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 3.92%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 3.92% |
| Dividend Growth (YoY) | 7.69% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.92% |
| Earnings Yield | 6.37% |
| FCF Yield | 8.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |